Skip to main content
International Journal of Environmental Research and Public Health logoLink to International Journal of Environmental Research and Public Health
. 2022 Aug 3;19(15):9533. doi: 10.3390/ijerph19159533

Effects of Tribulus terrestris L. on Sport and Health Biomarkers in Physically Active Adult Males: A Systematic Review

Diego Fernández-Lázaro 1,2,*, Cesar I Fernandez-Lazaro 3,*, Jesús Seco-Calvo 4,5, Evelina Garrosa 6, David P Adams 7, Juan Mielgo-Ayuso 8
Editors: Paul B Tchounwou, Oliver Grundmann
PMCID: PMC9368143  PMID: 35954909

Abstract

Tribulus terrestris L. (TT) is a plant used in traditional Chinese medicine, Ayurvedic medicine, and sports nutrition to improve health and performance. However, no conclusive evidence exists about the potential beneficial effects of TT on sport and health biomarkers in physically active adults. Based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and the modified McMaster Critical Review Form for methodological quality assessment, we systematically reviewed studies indexed in Web of Science, Scopus, and PubMed, to assess the effects of TT on immunological, hematological, biochemical, renal, lipidic, hormonal behavior, and anti-inflammatory response in physically active adult males. Among 340 records identified in the search, a total of 7 studies met the inclusion and exclusion criteria. Overall, participants supplemented with TT displayed significant improvements in lipid profile. Inflammatory and hematological biomarkers showed moderate beneficial effects with no significant changes on renal biomarkers. No positive effects were observed on the immune system response. Additionally, no TT-induced toxicity was reported. In conclusion, there was no clear evidence of the beneficial effects of TT supplementation on muscle damage markers and hormonal behavior. More studies are needed to confirm the benefits of TT due to the limited number of studies available in the current literature.

Keywords: Tribulus terrestris, sport supplement, biomarkers, physically active adults, systematic review

1. Introduction

Sports nutrition influences athletes’ health and sports performance [1]. When the nutritional recommendations are not sufficient to meet athletes’ requirements, athletes resort to using supplements to improve their athletic performance [2]. Dietary supplements are intended to cover the specific nutritional needs of physically active populations that may vary depending on the intensity and duration of exercise, sport discipline, time of the season, age, physical condition, and external environment [3]. Herbal supplements contain active botanical phytochemicals (phenolic acids, alkaloids, flavonoids, glycosides, saponins, and lignans) extracted from seeds, gums, roots, leaves, bark, berries, or flowers, of the plants [4]. Sports supplements may additional help to maintain athletes health and improve and maximize their athletic performance [5].

Ergo nutritional supplement sales have annually increased in the U.S. market, and it is estimated an annual growing rate of 8.9% over the next years [6]. One type of dietary supplements used in exercise and sports are herbal supplements [7], which are ranked second in sales in the U.S. dietary supplement market, only behind vitamin supplements [6]. Among herbal supplements, an extract of an exotic plant called Tribulus terrestris L. (TT) [7], has increased popularity among consumers.

TT is an herbaceous plant originally from India that belongs to the Zygophyllaceae family that comprises about 20 worldwide species. TT is known variously as “Tribulus”, “puncture vine”, “caltrop”, “goat head”, “puncture weed”, “Mexican sandbur”, “Texas sandbur” or “bullhead”, among other names. TT predominantly grows in the countries around the Mediterranean Sea and in sub-tropical regions around the world [8]. TT is a popular in traditional Chinese medicine and it has been widely used in many countries for thousands of years. TT (fruits and roost) has been mainly used for its potential cardioprotective, antiurolithic, antidiabetic, anti-inflammatory, antitumor, and antioxidant effects [9]. TT is composed of saponins, polyphenols, flavonoids, glycosides, alkaloids, and tannins [8]. Steroidal compounds, such as saponins, are heterosides consisting of a glycoside and a genin part, which can be steroidal or triterpene in nature. Steroid genins are derived from a hexacyclic skeleton of 27 carbon atoms, which is the spirostane nucleus [8,10]. Saponins are responsible for the positive physiological effects of TT on sexual performance, coronary heart disease, avoidance of ischemia/reperfusion injury to the heart, and modulation of hypertension [8,10].

Currently, products with TT extracts are commonly used by numerous athletes and non-athletes to improve testosterone levels and strength performance [11]. TT is attractive for athletes because of its potential ergogenic effects on sports performance [12], improving recovery after exercise [13], strength, and stimulating skeletal muscle hypertrophy [14] associated with TT as a testosterone booster [11], and promoting muscle anabolism [10,13]. These effects have been suggested to be linked to the saponins contained in TT [15]. The saponins of TT could exert an anabolic/androgenic influence by activating endogenous production of testosterone and luteinizing hormone (LH), which may stimulate muscle growth (7,8). The polyphenols and flavonoids contained in TT act as antioxidants because they effectively scavenge free radicals in a concentration-dependent manner [8,10]. Moreover, TT may reduce inflammation [16] by attenuating muscle damage [17] and oxidative damage [18].

Blood circulation is responsible for biochemical, metabolic, hormonal, and immunological processes, and for maintaining homeostasis in the body. Therefore, it is important to assess the physiological changes and adverse effects that may occur under the influence of sports activity or nutritional supplements used through biomarker analysis [19]. Additionally, knowledge of the physiological action of supplements for physicians, nutritionists, coaches, and athletes in the sports field may be of interest considering many new over-the-counter herbal products, with little evidence given the limited number of clinical trials and updated information. To date, there are scarce studies on the effects of TT on sports biomarkers in healthy physically active adults. Biomarker monitoring may provide crucial information to adjust exercise workloads to maintain an optimal level of health. Thus, the purpose of this study was to systematically review current studies on the potential effects of TT supplementation on immunological, hematological, and biochemical biomarkers, hormonal behavior, lipid profile, renal function, and anti-inflammatory activity in physically active healthy adult males.

We used the PICO model according to the standard methods proposed by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Guidelines (PRISMA) [20] as follows: Population: physically active healthy adult males; Intervention: supplementation with TT; Comparison: placebo/control group or pre/post comparison data group; Outcomes: immunological (white blood cells [WBC], lymphocytes [LYM], monocytes [MON], and granulocytes [GRAN]); hematological (hemoglobin [HB], hematocrit [HCT], and red blood cells [RCB]); biochemical (creatine kinase [CK], lactate dehydrogenase [LDH], and bilirubin [BIL]); hormonal (testosterone, dihydrotestosterone [DHT], estradiol [E2], luteinizing hormone [LH], insulin-like growth factor [IGF-1], insulin-like growth factor binding protein [IGFBP-3], growth hormone [GH], cortisol, ratio testosterone/cortisol, and ratio testosterone/epitestosterone); lipidic (cholesterol [Chol], triglycerides [Tg], low-density lipoprotein [LDH-Chol], high-density lipoprotein [HDL-Chol]); renal (creatinine [Cr], uric acid [Ua]; blood urine nitrogen [BUN], urea); inflammatory (interleukin 6 [IL-6], high-sensitivity C-reactive protein [Hs-CRP], erythrocyte sedimentation rate [ESR]) biomarkers.

2. Materials and Methods

2.1. Search Strategy

We established a structured search via the databases Scopus, Web of Science (WOS), and Medline (PubMed) for studies published from database inception to 29 April 2022. The search strategy contained a mix of Medical Subject Headings (MeSH) and free words for key concepts related that included: (“Tribulus” OR “puncture vine” OR “caltrop” OR “goat head”, “puncture weed” OR “Mexican sandbur” OR “Texas sandbur” OR “bullhead”) AND (“Immunological” OR “Biochemical” OR “Hematological” OR “Hormonal” OR “ Lipid profile” OR “Inflammatory”) AND (“Effects” OR “Biomarkers” OR “Parameters” OR “Bioindicators” OR “Biological Activity” OR “Pathways”). The search for published studies was independently performed by 2 authors (D.F.L. and J.M.A.) and disagreements about records were resolved by a third reviewer (J.S.-C.)

2.2. Selection Criteria

The following inclusion criteria were applied to select studies: (a) original records with randomized and non-randomized trials, double-blind or parallel controlled design; (b) records that evaluated the impact of TT supplementation administered alone in physically active adult males; (c) records with specific information on the dose of TT intake and intervention period; (d) studies with information about the type of pharmaceutical form used for the supplementation (pills, tablets, gel caps, liquids); (e) records that examined at least one reported outcomes related to any of the hematological, inflammatory, antioxidant, and biochemical biomarkers before communicated. On the other hand, the exclusion criteria were the following: (a) studies conducted on animals, and/or in vitro studies; (b) studies in which TT was administered with other supplements or administered as a combination; (c) records in which the outcomes were not related to sports performance or health; (d) editorials, reviews, notes, and any other non-original studies; (e) studies conducted in participants with any cardiovascular, metabolic, musculoskeletal, or other chronic disorder.

2.3. Quality Assessment

The methodological quality assessment of the selected records was performed using the McMaster University Occupational Therapy Evidence-Based Practice Research Group [21]. The aim of this evaluation was to exclude studies with poor methodology.

2.4. Data Extraction

The following information was extracted from each study included in the systematic review: included name of the first author; publication year; country where the study was conducted; study design; sample size; participants’ sex and age; weight or body mass index (BMI); dosage, i.e., specific amount, number, frequency, and percentage of saponins), timing of the supplementation; duration of intervention; outcomes reported; and final results. Two investigators (D.F.-L. and J.M.A.) conducted the data extraction process using a spreadsheet. In case of disagreements related to the data extraction, a third author reviewer (J.S.-C.) was involved in the process.

3. Results

3.1. Study Selection

A total of 340 studies were identified, 334 studies were from 3 electronic databases WOS, SCOPUS, and PubMed, and 6 studies were retrieved from reference lists of selected electronic databases studies. After exclusion of 273 duplicates, a total of 61 articles identified in databases and registries were examined. After evaluation of the title and abstract, 17 articles were considered as potential registries. After review of the full text and evaluation of potential records from databases and registries as well as other sources, 7 [12,14,15,17,22,23,24] studies were included in the systematic review (Figure 1).

Figure 1.

Figure 1

Flow diagram depicting the identification and selection processes of relevant studies according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

3.2. Quality Assessment

Four studies [12,14,15,17] were considered as “excellent quality” and 3 [22,23,24] as “very good quality” (Table 1).

Table 1.

Results of the methodological quality assessment of included studies—McMaster Critical Review Form for Quantitative Studies [21].

Study Item Total % Quality Score
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Ma et al., 2017 [12] 1 1 1 1 0 1 1 1 1 0 1 1 1 1 1 1 15 93.8 E
Rogerson et al., 2007 [14] 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 15 93.8 E
Fernández-Lázaro et al., 2021 [15] 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 16 100 E
Talemi et al., 2021 [17] 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 16 100 E
Milasius, et al., 2019 [22] 1 1 1 1 0 1 1 0 1 1 1 0 1 1 1 1 13 86.7 VG
Poprzecki et al., 2005 [23] 1 1 1 1 0 1 1 1 0 0 1 1 1 1 1 1 13 86.7 VG
Wilk et al., 2012 [24] 1 1 1 1 0 1 1 0 0 1 1 1 1 1 1 1 13 86.7 VG

Abbreviations: 0 = not fulfilled criterion; 1 = fulfilled criterion; E = excellent; VG = very good. Item 1: study purpose; item 2: literature review; item 3: study design; item 4: blinding; item 5: sample description; item 6: sample size; item 7: ethics and consent; item 8: validity of outcomes; item 9: reliability of outcomes; item 10: intervention description; item 11: statistical significance; item 12: statistical analysis; item 13: clinical importance; item 14: conclusions; item 15: clinical implications; item 16: study limitations.

3.3. Characteristics of the Participants and Interventions

The characteristics of the participants are shown in Table 2. The total number of volunteers was 165 men, all of them healthy (without any chronic conditions that prevented the practice of physical activity) and physically active. Three studies [12,14,23] included elite athletes who practiced basketball [23], rugby [14] and boxing [12]. Two studies [15,22] included highly trained athletes with at least 20 months of CrossFit® [15] and endurance sports experience within the study program of physical education [22]. Two studies [17,24] did not include participants with regular physical activity habits prior to baseline. However, in these studies participants performed either 4 sessions of scheduled physical activity (aerobic and anaerobic) [24] or were instructed to maintain routine daily physical activity [17] during the length of the study.

Table 2.

Characteristics of participants and supplementation protocols of the selected studies.

Characteristics Types Study
Participants Elite athletes [12,14,23]
Well-trained athletes [15,22]
No regular training before the study [17,24]
Supplementation product Manufactured [17,24]
Registered product® [12,14,15,22,23]
% Saponins of the supplementation product 100% [22,23,24]
60% [14]
>40% [15,17]
40% [12]
Total dose (mg) × day−1 1875 [22]
1800–2700 [23]
1250 [12]
900–1800 [24]
770 [15]
500 [17]
450 [14]
Duration 12 weeks [24]
6 weeks [15]
5 weeks [14]
4 weeks [23]
3 weeks–4 weeks (rest)–3 weeks [12]
2 weeks [17]
20 days [22]
Dose schedule After exercise and before going to sleep [23]
a.m. [12]
a.m. and before going to sleep [24]
a.m. and p.m. [17,22]
No reported [14,15]

Abbreviations: a.m. = ante meridiem; p.m. = post meridiem.

TT supplementation was used in 5 studies [12,14,15,22,23] as commercially registered product and in 2 studies [17,24] was specifically prepared for the intervention. Doses of TT supplementation varied from 1875 mg [22] to 450 [14] mg, with 2 studies that supplemented with 2 doses, 1800 mg or 2700 mg [23], and 900 mg or 1800 mg [24]. Supplementation duration varied from 12 weeks [24] to 20 days [22]. Authors supplemented participants after breakfast and before going to sleep [23], in the morning and before going to sleep [24], in the morning [12] or in the morning and afternoon [17,22]. Two studies did not report dose schedule [14,15]. No adverse effects were reported, and, in general, the participants tolerated the TT supplementation well [12,14,15,17,22,23,24].

3.4. Outcome Evaluation

Table 3 summarizes the contents of the studies contained in this systematic review.

Table 3.

Studies included in the systematic review of the effect of Tribulus terrestris L. on hematological and biochemical markers, hormonal behavior, and oxidant response in healthy adults.

First Author, Year of Publication, and Country Study Design Participants (Baseline Sample Size and Characteristics, Withdrawals, and Final Group Sample Size) Intervention Outcomes Results
Ma et al., 2017,
China [12]
Random-ized, double-blind, placebo-controlled trial 15 Inline graphic boxers (national second-level athletes, 2–3 y of training)
Age (mean ± SD):
CG: 16.6 ± 1.9 y
IG: 16.1 ± 1.8 y
Weight (mean ± SD):
CG: 62.8 ± 15.2 kg
IG: 64.1 ± 6.6 kg
Body fat (mean ± SD):
CG: 9.6 ± 3.2%
IG: 9.8 ± 2.4%
2 withdrawals/lost to follow-up
13 participants completed the study
7 participants CG
6 participants IG
2 × 625 mg TT (Pronova Biocare, Sweden)
(>40% steroidal saponins)
“Placebo” (starch)
2 cap every morning
3 wk supplementation
For high-volume training
4 wk rest
3 wk supplementation
For high-intensity training
BUN
CK
DHT
T
IGF-1
IGFBP-3
IG vs. CG
high-volume training high-intensity training
↓BUN
↑CK
↓DHT
↓Testosterone
↓IGF-1
↓*IGFBP-3
↓BUN
↓*CK
↓DHT
↓Testosterone
↑IGF-1
↓*IGFBP-3
IG: change from baseline
high-volume training high-intensity training
↑BUN
↑CK
↓DHT
↑Testosterone
↓IGF-1
↓*IGFBP-3
Inline graphicBUN
↓*CK
↓DHT
↑Testosterone
↓IGF-1
↓*IGFBP-3
Rogerson et al., 2007,
Australia [14]
Random-ized, double-blind, placebo-controlled trial 22 Inline graphic male elite rugby players
Age (mean ± SD)
CG: 19 ± 1.3 y
IG: 20.5 ± 3.8 y
Weight (mean ± SD)
CG: 87.6 ± 9.0 kg
IG: 88.5 ± 10.5 kg
No withdrawals reported
11 participants CG
11 participants IG
450 mg/cap of TT extract (Body Science, Sydney, Australia) (60% steroidal saponins; 40% flavonoids, alkaloids, phenols).
“Placebo”
inert herbs identical TT
1 cap × day
5 wk
Testosterone/Epites-tosterone IG vs. CG
↓Testosterone/Epitestosterone
IG: Change from baseline
↓Testosterone/Epitestosterone
Fernández-Lázaro et al., 2021,
Spain [15]
Random-ized, single-blind, placebo-controlled trial 30 Inline graphic CrossFit®-trained athletes
Age (mean ± SD):
CG: 33.1 ± 5.7 y
IG: 32.9 ± 6.3 y
Body mass (mean ± SD)
CG: 80.1 ± 10.7 kg
IG: 81.2 ± 11.5 kg
No withdrawals reported
15 participants CG
15 participants IG
2 caps × 385 mg TT (Quamtrax Europe, Spain)
(40% steroidal saponins)
“Placebo” (maltodextrin)
2 caps empty stomach
6 wk
Testosterone
Cortisol
Testosterone/Cortisol
IG vs. CG
↑*Testosterone
↓Cortisol
↑Testosterone/Cortisol
IG: Change from baseline
Inline graphicTestosterone
↓Cortisol
↑Testosterone/Cortisol
Talemi et al., 2021,
Iran [17]
Random-ized, double-blind, placebo-controlled trial 18 Inline graphic healthy physically active through resistance exercise training
Age (mean ± SD)
22.44 ± 2.54 y
BMI (mean ± SD)
26.15 ± 1.62 kg/m2
No withdrawals reported
9 participants CG
9 participants IG
2 × 250 mg TT
TT powder and extract
(27 mg total phenolic content, 100 mg furostanol saponins,
and 34 mg total flavonoids)
“Placebo” (maltodextrin)
2 wk
daily: morning and evening intakes after meal
IL-6
Hs-CRP
CK
LDH
IG vs. CG
↓IL-6
↓Hs-CRP
↓CK
↓*LDH
IG: Change from baseline
↑*IL-6
↑Hs-CRP
↓CK
↑LDH
Milasius, et al., 2019,
Lithuania [22]
Placebo-controlled study 32 Inline graphic athletes’ endurance sport
Age (range): 20-22 y
Weight (mean ± SD):
CG 76.0 ± 8.2 kg
IG 75.3 ± 7.7 kg
BMI (mean ± SD)
CG: 22.9 ± 1.7 kg/m2
IG: 23.1 ± 1.9 kg/m2
No withdrawals reported
12 participants CG
20 participants IG
3 × 625 mg TT powder
(Optimum Nutrition, EE.UU.) (100% furostanol saponins)
a.m. (1 × cap) and p.m. (2 × caps) intakes
20 days
RCB Hb
HCT MVC
ERS WBC LYM MON GRAN
CK Cr
Ua Urea
Chol Tg
Bilirubin
Testosterone
Cortisol
IG vs. CG
↓RCB ↑HB
↑HCT ↓MVC
↑ERS ↓WBC
↓LYM ↑MON ↑GRAN
↑*CK ↓Cr
↑Ua ↓Urea
↓Chol ↑Tg
↓Bilirubin
xTestosterone
xCortisol
IG: Change from baseline
↓RCB ↓HB
↑HCT Inline graphicMVC
↓ERS Inline graphicWBC
↓*LYM ↓MON ↑*GRAN
↑*CK ↓Cr
↓Ua ↓Urea
↓Chol ↑Tg
↓Bilirubin
↑Testosterone
↑Cortisol
Poprzecki et al., 2005,
Poland [23]
Placebo-controlled study 24 Inline graphic competitive basketball players
Age (mean ± SD): 26 ± 3.4 y
Weight (mean ± SD): 91.5 ± 9.0 kg
No withdrawals reported
8 participants CG
8 participants IG
Tribusteron 90
450 mg/cap
(100% Steroidal saponins)
1st 4 caps × day, 2 wk
(1800 mg saponins)
2st 6 caps × day, 2 wk
(2700 mg saponins)
“Placebo”
450 mg/caps gelatin.
Twice daily: 30 min before training and 20 min before going to bed
4 wk
Testosterone
Luteinizing Hormone
Estradiol
IG vs. CG
↓Testosterone
↑Luteinizing Hormone
↑Estradiol
IG: Change from baseline
↓*Testosterone
↑Luteinizing Hormone
↑*Estradiol
Wilk et al., 2012,
Poland [24]
Random-ized, placebo-controlled trial 14 Inline graphic with 4 training sessions * wk, (2 sessions anaerobic power, 2 of aerobic endurance exercise)
Age (range): 45–60 y
BMI (range): 25–30 kg/m2
Body fat (range): 23–30%
No withdrawals/lost to follow-up reported
1st 6 wk: 900 mg TT
(100% steroidal saponins)
2 caps × 300 mg morning on an empty stomach
1 cap × 300 mg bedtime
2nd 6 wk: 1800 mg TT (100% steroidal saponins)
4 caps × 300 mg morning on an empty stomach
2 caps × 300 mg bedtime
“Placebo”
caps gelatin
12 wk
Chol
LDH-Chol
HDL-Chol
GH
IGF-1
Testosterone
IG vs. CG
↓*Chol
↑*HDL-Chol
↓*LDH-Chol
↑*GH
↑*IGF-1
↑*Testosterone
IG: Change from baseline
↓*Chol
↑*HDL-Chol
↓*LDH-Chol
↑*GH
↑*IGF-1
↑*Testosterone

Abbreviations: ↑ = no significant increase; ↓ = no significant decrease; Inline graphic = no significant change. ↑* = significant increase; ↓* = significant decrease; CG = control group; IG = intervention group; wk = weeks; caps = capsules; TT = Tribulus Terrestris; DHT = dihydrotestosterone; IGF-1 = Insulin-like growth factor 1; IGFBP-3 = Insulin-like growth factor binding protein 3; GH = growth hormone; CK = creatine kinase; LDH = lactate dehydrogenase; Cr = creatinine; Ua = uric acid; BUN = blood urine nitrogen; RCB = red blood cells; HB = Hemoglobin; HCT = Hematocrit; ESR = erythrocyte sedimentation rate; MCV = mean corpuscular volume; WBC = white blood cells; LYM = lymphocytes MON = monocytes; GRAN = granulocytes; Chol = cholesterol; Tg = triglycerides; LDH-Chol = low-density lipoprotein; Inline graphic = males; HDL-Chol = high-density lipoprotein; IL-6 = interleukin 6; Hs-CRP = high-sensitivity C-reactive protein; y = years; kg = kilograms; m2 = square meters; mg = milligrams.

3.4.1. Immunological Biomarkers

One study [22] analyzed the impact of TT on immunological markers. In LYM, MON, and GRAN, no significant changes were observed when comparing the intervention group with respect to the control group. However, a significant increase in GRAN and a significant decrease in LYM were observed after 20 days of TT supplementation compared to baseline levels.

3.4.2. Hematological Biomarkers

Hematological biomarkers were evaluated by Milasius et al. [22]. This study observed a non-significant increase on HCT and HB, however, RCB and MCV showed a downward trend when comparing the TT supplementation group with the control group. Only HCT levels showed a non-significant increase from baseline to the end of training in the TT group [22].

3.4.3. Biochemical Biomarkers

The effect of TT on CK was evaluated in 3 studies [12,17,22]. Ma et al. [12] showed that CK in the intervention group following high-intensity training was significantly lower than in the control group and from baseline to the end of the supplementation. However, Milasius et al. [22] described contrary results for athletes in endurance sports. In addition, in 1 of these studies [17], post-exercise values of this CK in the TT group were moderately lower compared to its pre-exercise levels. Moreover, differences between the groups regarding post-exercise CK were not significant [17].

LDH level in the TT group was significantly lower than in the placebo group in response to resistance exercise training [17]. BIL concentration showed a decreasing trend when comparing the TT supplementation group with the control group and when examining changes from baseline [22].

3.4.4. Renal Biomarkers

The impact of TT on renal biomarkers, Cr, Ua, Ure, and BUN were evaluated in 2 studies [12,22], observing no significant changes.

3.4.5. Lipid Biomarkers

Chol and LDH-Chol levels were significantly reduced and HDL-Chol were significantly increased among participants in the TT intervention group compared with the control group [24] and investigators also observed Chol and LDH-Chol levels were significantly reduced and HDL-Chol have significantly increased changes from baseline to the end of the intervention [24]. Moreover, Milasius et al. [22] reported a non-significant improvement in Tg over the control group and from baseline to the end of supplementation.

3.4.6. Inflammatory Biomarkers

Inflammatory biomarker studies were examined in 2 studies [17,22]. IL-6 and Hs-CRP showed a downward trend when comparing the TT supplementation group with the control group [17], however, examining changes from baseline observed significant increases in IL-6 and Hs-CRP [17]. One study [22] reported changes in ESR during the study, but non-statistical significance.

3.4.7. Hormonal Biomarkers

Testosterone levels were examined in 5 studies [12,15,22,23,24]. Two studies reported significant increases in testosterone levels in the TT intervention group relative to the control [15,24]. Examining changes from baseline, 2 studies showed a trend improvement [12,22] and other investigators [24] observed significant increases in testosterone levels. However, the study by Poprzecki et al. [23] reported significant decreases in testosterone levels. Regarding cortisol levels, 2 studies showed contradictory findings when comparing the TT supplementation groups from baseline [15,22]. IGF-1 and GH observed significantly increased levels from baseline to the end of the intervention, and also between the intervention and control group [24]. However, Ma et al. [12] showed a decreasing trend in all experimental situations for IGF-1 and DHT.

4. Discussion

The purpose of this systematic review was to critically evaluate the effects of TT supplementation on sports biomarkers in physically active healthy adult males. A total of 7 studies met the inclusion/exclusion criteria. Participants supplemented with TT presented significant improvements in lipid profile. Inflammatory and hematological biomarkers showed moderate beneficial effects with no significant changes on renal biomarkers. However, TT seemed not to have a positive effect on the immune system. There was no clear evidence of the beneficial effects of TT supplementation on muscle damage markers and hormonal behavior. No TT-induced toxicity was reported.

4.1. Tribulus terrestris L. Supplementation

Supplementation doses administered in interventions varied from 2700 [23] to 450 mg [14], from 20 days [22] to 3 months [24]. None of the 165 men included in this systematic review suffered adverse effects during the TT supplementation protocol. No significant abnormal changes in renal function biomarkers (Cr, Ua, Urea, and BUN) were found [12,22], and a downward trend on BIL levels was observed [22]. Therefore, no drug-induced nephrotoxicity or hepatotoxicity was reported. This is not consistent with other human clinical studies that have reported gastrointestinal problems, such as stomach pain or gastric reflux [25,26], gynecomastia [27], priapism [28], nephrotoxicity [29,30], hyperbilirubinemia [29], hepatotoxicity, and neurotoxicity [30] when taking TT. Sleep disturbances, exhaustion and fatigue, hypertension, and elevated heart rate have been reported after administration of TT at doses ≥1000 mg per day [10,29]. In rats, toxic effects on liver and kidney have been observed, and an in vitro study has indicated cytotoxicity and/or genotoxic activity [31] and nephrotoxicity [32]. The report of the Scientific Committee of the Spanish Agency for Consumer Affairs, Food Safety and Nutrition (AECOSAN) reported that the recommended daily intake of TT would be between 250 and 9000 mg [31]. TT has not been listed as a banned substance by the World Anti-Doping Agency (WADA) [33]. However, TT may increase the testosterone/epitestosterone ratio in urine above the WADA permitted limits (4:1) [14], and may cause athletes to inadvertently test positive for testosterone [33]. There are some sports agencies such as the Australian Institute of Sport, the National Centre for Sports Medicine in Poland and the Medical Commission of the Polish Olympic Committee, and the Canadian Cycling Association that may issue a positive test result in a doping control by TT supplementation [9].

4.2. Hematological Biomarkers

The study by Milasius et al. [22] included in this systematic review, showed no abnormal changes in hematological biomarkers during 1875 mg per day TT supplementation containing 100% saponins. Investigators observed a moderate increase of HCT and HB compared to control group, but did not have positive effect on RCB and MVC. TT does not directly affect erythropoietic activity in persons. This property may be explained because TT supplementation showed a trend in improvement of testosterone levels [22]. Testosterone stimulates erythropoiesis, induces erythrocytosis, and increases HCT levels in a dose-dependent manner without an associated increase in erythropoietin levels [34]. Another pathway may be through the action of DHT, Protodioscin (5,6-dihydroprotodioscin, neoprotodioscin), which is believed to increase the conversion of testosterone to DHT, which promotes red blood cell production [10]. Physical activity causes alterations in different hematological parameters. Thus, the adequate hematological status in the organism is an essential factor that conditions physical capacity, sports performance, and health in athletes. Therefore, those factors that improve the transport and utilization of oxygen at the muscular level [1]. Thus, steroidal saponins from TT, like Protodioscin, could have beneficial effects on physical fitness [9], by improvements on HB and HCT, and other ergogenic aids such as iron supplements [3].

4.3. Immunological Biomarkers

Steroidal saponins contained in TT had demonstrated immunostimulant activity on macrophage activity in vitro assays and activation of non-specific immunity in animal model [35]. In addition, TT showed an enhancement of B cell activity with significant increases on serum antibody titers that are potentially effectors of the humoral response [36]. These findings are contradictory to those described by Milasius et al. [22], where these investigators asserted a negative effect on the immune system. Milasius et al. [22] have reported that 1875 mg of TT for 20 days induces a change in leukogram transformed into granulocytes with substantial decrease in lymphocytes and significant increase of neutrophils, basophils, and eosinophiles in endurance athletes. In this regard, dose and/or the high percentage of steroid saponins in TT supplementation could be responsible for the immunosuppression, which could be like that of corticosteroids [37].

However, it should be considered that intense and acute physical exercise is accompanied by responses that are remarkably similar in many respects to those induced by infection, sepsis, or trauma. The number of circulating leukocytes (mainly lymphocytes, monocytes, and neutrophils) and their magnitude are related to both the intensity and duration of exercise [38]. For this reason, it could be hypothesized that the effects on the cells of the immune system are not due to TT-induced toxicity, but because TT is not able to restore the effects that exercise has on the immune system. In this sense, no immunosuppressive effect of TT has been reported to date [10,29]. Therefore, we recommend evaluating blood immunological biomarkers during periods of TT supplementation in athletes.

4.4. Biochemical Biomarkers

Intense and prolonged periods of physical activity increases circulating levels of LDH and CK, which negatively affect athletes by decreasing muscle performance [1]. This systematic review examined CK [12,17,22], and LDH [17], as potent muscle damage biomarkers. In these studies, TT supplementation demonstrated a significant reduction for CK activity (during high-intensity training) [12] and LDH activity (during resistance-exercise training) [17]. Furthermore, in 1 of these studies [17], post-exercise CK activity was moderately lower compared to its pre-exercise levels. These results are consistent with previous animal study [39]. Potentially, the decrease in CK or LDH after TT supplementation could be attributed to an antioxidant role [8]. In this sense, the protective effect appears to be mediated directly either through inhibition of through inhibition of tissue peroxidation [40] or induced increase serum superoxide dismutase (SOD) activity [41]. Previously, the anti-inflammatory effect of TT has been reported by its inhibitory action on cyclooxygenase-2 (COX-2) expression [42]. This property could influence the reduction of CK activity. The action of TT could markedly reduce histamine and/or prostaglandin production by its inhibitory action on COX-2 [2]. Consequently, in local areas of inflamed skeletal muscle, membrane permeability would be reduced, thereby reducing the intracellular-intravascular flux of CK. However, Milasius et al. [22] found significant increases in CK activity. These discrepancies may be due to the composition of the TT supplement administered. Perhaps, several bioactive components of TT such as flavonoids, alkaloids, phenols, and saponins [12,17] are necessary to have an antioxidant and/or anti-inflammatory effect, and not only steroidal saponins [22].

Another blood biomarker included in this study is BIL [22]. In athletes, BIL elevations are frequent and derive from repeated micro-trauma that breaks down HB and metabolizes into BIL, demanding strength training or high levels of physical and/or mental stress due to sports competitions [43]. Moreover, Milasius et al. [22], have observed a downward trend in the concentration of BIL, liver function biomarker. TT showed a remarkable hepatoprotective activity, that seems to be related to inhibition of lipid peroxidation and increased levels of antioxidant enzymes, in addition to free radical scavenging action [44,45]. TT’s flavonoids would enhance the viability and cellular leakage of transaminases (AST, ALT) and could be responsible for protecting the liver against oxidative damage and tissue-damaging enzymatic activities. However, we must also consider that TT plant contains alkaloids, steroidal glycosides, and steroidal saponins [46].

4.5. Inflammatory Biomarkers

It is known that exercise induces an increase in plasma levels of IL-6, which may be the indicator of a more intense inflammatory response [38]. Increased IL-6 precedes inflammatory cytokines such as TNF-α, macrophage inflammatory protein-1 (MIP), IL-4, IL-1, and acute phase proteins such as CRP [43]. This would have negative repercussions on the athlete’s muscular system due to increased inflammation or leukocyte infiltration. TT extracts are known to have anti-inflammatory activities in in vivo and in vitro assays [46]. Additionally, TT ’s properties would include down-regulation of enzymes responsible for the production of cytokines and inflammatory mediators [47]. These findings were in agreement with the only study that evaluated the anti-inflammatory effect of TT, then 500 mg × day−1 for 2 weeks of TT supplementation was sufficient to induce a moderate but not statistically non-significant decrease in IL-6 and Hs-CRP [17]. A plausible pathway would be that TT inhibits NF-κB a signaling pathways [48]; this property is like that of another herbal supplement, curcumin [2]. Down-regulation of NF-κB [48], plus inhibition of COX-2 [42], allows TT to suppress leukocyte infiltration, activation, and maturation, as well as the production of proinflammatory mediators TNF-α and IL-4, at the focus of inflammation. Control of IL-6 levels could attenuate a wide range of inflammatory events that affect the homeostasis of the organism. These properties are similar to other nutritional supplements such as glycophosphopeptical AM3 [37]. ESR is an indirect measure of the degree of inflammation present in the body [43]. One study included in this systematic review [22] showed modest increases in ESR in TT group. Maybe this is because the anti-inflammatory effect requires several active ingredients of TT and saponins alone would not be sufficient.

Overall, TT, as a nutraceutical, has been used in traditional Chinese medicine, in Ayurvedic medicine in India, as well as by modern herbalists as an adjuvant for its various anti-inflammatory properties in inflammation-mediated diseases such as diabetes, obesity, pancreatitis, cancer, inflammatory bowel disease, kidney disease, and arthritis [49].

4.6. Renal Biomarkers

Cytoprotective power on the cells of the renal system would suggest improvements in renal function after TT’s treatment [8], but 2 studies included in this systematic review did not significantly change after TT supplementation in renal biomarkers [12,22]. All of them were in physiological range values, suggesting that there was no TT-induced renal toxicity. These results agree with those reported by Gandhi et al. [32] who neither observe improvements in renal function nor found TT-induced toxicity. However, kidney injury after TT supplementation has been described [29,30].

Concerning the Cr, Ua, Urea, and BUN (high-intensity training) levels, athletes of the studies integrated in this systematic review did non-significantly decrease when compared with baseline (TT group) [12,22]. BUN (high-volume training) levels increased from baseline but were not observed when compared with control groups [22]. The concentration of BUN remained within normal range (7–21 mg/dL) and most likely reflected muscle destruction increments due to high-volume training [22]. In this line, studies in rats [50] and renal epithelial cell lines (NRK-52E) [51], TT showed significant dose-dependent protection against elevation of biochemical parameters in urine. This premise would add new perspective of TT on the maintenance in physiological range of renal biomarkers that are increased after exercise.

4.7. Lipid Biomarkers

Moderate physical exercise is associated with a healthy plasma lipid profile and a lower risk of coronary artery disease and cardiovascular mortality [52]. Physical exercise increases plasma HDL-Chol values and decreases LDL-Chol and Chol [53,54]. However, stressful physical exercise can increase cardiovascular risk [55]. Direct and significant associations have been found with the degree of physical stress to which the different athletes were subjected. The most common alterations in lipid biomarkers were on HDL-Chol and LDL-Chol [55,56].

TT has demonstrated lipid-lowering activity [8]. TT supplementation in animal models leads to a decrease in Chol and LDL-Chol, and an increase in HDL-Chol levels in the blood [57,58]. Additionally, the lipid-lowering preventive effect of TT was demonstrated on diet-induced hyperlipidemia in mice by the decrease in Chol and LDL-Chol blood levels [59]. These results are consistent with 3 studies included in the review in which TT has shown lipid-lowering activity [17,22,24]. Phenolic compounds seem to be responsible for the direct effects and saponins for the preventive effects on the lipid profile [46]. Phenolic compounds may be increased lipase activity in skeletal muscle and decreased activity in adipose tissues which stimulate the use of plasma triglycerides as energy fuel by muscle and blocks their storage as fat [57]. Saponins would increase the activity of SOD in the liver, improving the antioxidant capacity [59]. These results support the use of TT as a sport supplement to counterbalance and equilibrate lipid profile to create lipid level balances in situations of high physical stress or demanding exercise.

4.8. Hormonal Biomarkers

Intensive exercise has been shown to induce a dysfunction of the hypothalamic-pituitary-testicular axis, especially testicular impairment by causing a suppression of testosterone secretion during the latter stages of exercise. Additionally, during intense prolonged exercise, Adrenocorticotropic Hormone (ACTH) concentrations increase, resulting in a significant release of cortisol [1]. These alterations on hormonal behavior would cause sports performance to decrease [5]. TT has become popular for its anabolic properties that could potentially raise the blood testosterone level and stimulate hypertrophy of the skeletal muscles of Bulgarian weightlifters [11].

Investigators in 4 studies reported beneficial effects of TT supplementation on testosterone levels [12,15,22,24]. These results are consistent with animal studies [13,60,61,62] or older men [63] in which TT has shown to increase testosterone. The properties of TT may also influence the effects on testosterone levels because of their pleiotropic effects such as: (i) direct action of the pituitary gland that secretes more LH; (ii) increased levels of dehydroepiandrosterone (DHEA) molecules; (iii) suppression of aromatase that prevents estrogen synthesis; (iv) antioxidant effect that protects against endothelial dysfunction in the gonads; (v) anti-inflammatory properties [8,46,64]. TT’s steroidal saponins, such as gitonin, protodioscin, and tribulosaponins A and B, would be responsible for stimulating testosterone production by these multiple pathways [46]. Nonetheless, in the study of Poprzecki et al. [23], included in the present review, the levels of testosterone when supplementing with TT significantly decreased. Moreover, TT provided no benefit on plasma testosterone levels in rugby players, with a marked decrease in the testosterone/epitestosterone ratio [14]. Likewise, other clinical trials reposted that TT was no more effective than placebo for serum total testosterone concentration [65]. The testosterone-enhancing direct actions of TT have been ratified by some investigators, as shown above, but are questioned by other studies.

The indirect hormonal behavior of testosterone showed contradictory results. Poprzecki et al. [23] showed a remarkable increases in LH, due to the direct action of steroid saponins on the pituitary gland which secretes more LH [46]. LH increases could stimulate testosterone levels due to indirect action where LH regulates the expression of 17β-hydroxysteroid dehydrogenase, which is the enzyme that converts androstenedione to testosterone [46]. However, no testosterone increases are observed after 4 weeks of TT supplementation [23]. Increases in E2 could decrease short-term testosterone levels by aromatase activity. Although, it is difficult to explain these elevated E2 levels by the anti-aromatase activity of the bioactive components of TT [8,11]. Perhaps the intensity and high levels of demand of professional basketball outweigh the effects of TT on hypothalamic-pituitary-testicular axis.

DHT is an active androgen of testosterone. Saponins, mainly protodioscin, induce the transformation of testosterone into DHT, through their intervention on the enzyme 5-α reductase [46]. Previously, significant increases on testosterone and DHT levels have been described in primates after TT administration compared to control [61]. However, Ma et al. [12] reported decreases in TT supplementation group in both testosterone and DHT hormones. These contradictory findings may be explained by the different percentage of steroidal saponins, the dose or the bioavailability of TT, which were higher in the animal study [61].

Two studies included in this review evaluated cortisol levels, showing opposite results. Milasius et al. [22], in endurance athletes, showed an elevation of cortisol from baseline but in the study conducted by Fernández-Lázaro et al. [15], in CrossFit® athletes, the results showed a decrease in cortisol from baseline and when compared to the control group. In addition, these investigators [15] described remarkable improvements in the testosterone/cortisol ratio which indicates adequate fatigue control may have mitigating effects on the hypothalamic-pituitary-adrenal (HPA) axis activity by cortisol-level reduction in athletes. This difference in the results may be influenced by the characteristics of the athletes in each group, the type of exercise performed or the supplementation strategy.

These results showed uncertainty about the use of TT as an anabolic sports supplement to counteract and balance biomarker levels to create balances at the hormonal level.

Athletes may prefer to use TT supplementation rather than other supplements due to its potential anabolic effects, uncommon side effects [15], and because TT is not listed as a banned substance by the WADA [33]. IGF-1 is a polypeptide hormone secreted by multiple tissues in response to GH. IGF-1 and GH have a great effect on muscle hypertrophy, muscle repair, alleviation of muscle damage, changes in body composition, and improvement of athletic performance. Downward alterations in GH and IGF-1 levels have been shown as a function of subject characteristics, physical activity (type, intensity, and duration), and training status [66]. A 12-week supplementation of TT showed significant improvements in blood concentration of GH and IGF-1 [24]. These results indicate that TT treatment may be a successful form of skeletal muscle protection and in accelerating skeletal muscle regeneration/repair. In opposition, supplementation with 1250 mg of TT extracts decreased the plasma level of IGFBP-3 and IGF-1 in male boxers after both types of training (volume/intensity) [12]. Nevertheless, it significantly alleviated muscle damage and promoted athletic performance. It is hypothesized that these findings may be mediated by the decrease in IGFBP-3, and late increasing IGF-1 bioactivity [12]. Although different results have been reported different effects of TT on IGF-1 and GH, the goal of supplementation is met by improving athletic performance and muscle condition.

Of particular interest for middle-aged adults are the results obtained in the study of Wilk et al. [24] on a population aged 45–60 years. In this study [24] significant improvements in hormonal behavior that could mitigate the effects of sarcopenia were observed. Sarcopenia includes an involution of skeletal muscle that is accentuated after the age of 40 years with losses in muscle strength, physical performance, and quantity/quality of skeletal muscle mass [67]. Restoration of hormonal homeostasis is one of the potential therapies to control sarcopenia [68]. Therefore, TT could restore and modulate the hormonal levels diminished by age.

There are many published reviews on the phytochemical and/or pharmacological profile of TT [46,64], however, this systematic review and reports concern the effects on sports biomarkers and health in healthy, physically active adults. So, this study could provide additional relevant information to the knowledge of TT. Regular physical exercise and sports supplementation induce physiological and metabolic adaptations, which influence sports performance [1]. To monitor these adaptations, blood biomarkers have been proposed as suitable markers to measure the effect of short- and long-term training/supplementation, but also to maintain health, identify chronic stress, inflammation, fatigue or as injury prevention [69]. Therefore, health and sports performance monitoring in regular exercisers would include biochemical, immunological, inflammatory, hormonal, and hematological parameters to ensure a correct state of health and the absence of any abnormality that may decrease exercise performance.

4.9. Limitations and Stregths

Several limitations need to be acknowledged. First, the systematic review included a limited number of records. Moreover, most of these studies included a small sample size and only male participants. Second, the intervention characteristics of the studies such intensity and duration of exercise, timing and dose of TT supplementation widely varied across studies. Despite these limitations, the strengths of this systematic review rely in the use of the PRISMA guidelines [20] and the McMaster Quantitative Review Form [21], the use of three electronic databases, the addition of grey studies to the search, and the inclusion of multiple outcomes generally described in herbal medicine to assess sports performance and health status.

5. Conclusions

The evidence presented in the studies in this systematic review showed that TT supplementation is safe although side effects have been reported in other animal and human studies. Given the improvements in certain biomarkers, it may also benefit physically active adults. The pleiotropic effect of TT may act to counteract and modulate certain physiological biomarkers out of the normal range by intense and stressful physical exercise. In this regard, some examples are hematological, lipid, renal, and hepatic biomarkers. There are doubts about the potential effect on muscle damage, anti-inflammatory effect, and hormonal biomarkers. In addition, it lacks effect on the immune system. However, more research is needed to confirm the potential health benefits of TT supplementation in healthy adults without chronic diseases.

Acknowledgments

The authors would like to thank the Neurobiology Research Group, Department of Cellular Biology, Histology and Pharmacology, Faculty of Medicine, the University of Valladolid for their collaboration on infrastructure computer support.

Author Contributions

D.F.-L. and C.I.F.-L.: conceived and designed the research, analyzed, and interpreted the data, drafted the paper, and approved the final version submitted for publication; J.M.-A. and J.S.-C.: analyzed and interpreted the data, critically reviewed the paper; E.G. and D.P.A.: writing—original draft preparation, critically reviewed the paper; E.G. and D.P.A.: interpreted the data and critically reviewed the paper. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All results are shown in the study.

Conflicts of Interest

The authors declare no conflict of interest.

Funding Statement

This research received no external funding.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Fernández-Lázaro D. Ph.D. Thesis. University of León; León, Spain: 2020. [(accessed on 7 May 2021)]. Ergogenic Strategies for Optimizing Performance and Health in Regular Physical Activity Participants: Evaluation of the Efficacy of Compressive Cryotherapy, Exposure to Intermittent Hypoxia at Rest and Sectorized Training of the Inspiratory Muscles. Available online: https://dialnet.unirioja.es/servlet/tesis?codigo=286163&info=resumen&idioma=SPA. [Google Scholar]
  • 2.Fernández-Lázaro D., Mielgo-Ayuso J., Calvo J.S., Martínez A.C., García A.C., Fernandez-Lazaro C.I. Modulation of exercise-induced muscle damage, inflammation, and oxidative markers by curcumin supplementation in a physically active population: A systematic review. Nutrients. 2020;12:501. doi: 10.3390/nu12020501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Fernández-Lázaro D., Mielgo-Ayuso J., Martínez A.C., Seco-Calvo J. Iron and physical activity: Bioavailability enhancers, properties of black pepper (bioperine®) and potential applications. Nutrients. 2020;12:1886. doi: 10.3390/nu12061886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Silano V., Coppens P., Larrañaga-Guetaria A., Minghetti P., Roth-Ehrang R. Regulations applicable to plant food supplements and related products in the European Union. Food Funct. 2011;2:710–719. doi: 10.1039/c1fo10105f. [DOI] [PubMed] [Google Scholar]
  • 5.Fernández-Lázaro D., Fernandez-Lazaro C.I., Mielgo-Ayuso J., Navascués L.J., Martínez A.C., Seco-Calvo J. The role of selenium mineral trace element in exercise: Antioxidant defense system, muscle performance, hormone response, and athletic performance. A systematic review. Nutrients. 2020;12:1790. doi: 10.3390/nu12061790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Dietary Supplements Market Size & Trends Report, 2021–2028. 2021. [(accessed on 14 July 2022)]. pp. 1–8. Available online: https://www.grandviewresearch.com/industry-analysis/dietary-supplements-market.
  • 7.Williams M. Dietary Supplements and Sports Performance: Herbals. J. Int. Soc. Sports Nutr. 2006;3:1. doi: 10.1186/1550-2783-3-1-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chhatre S., Nesari T., Somani G., Kanchan D., Sathaye S. Phytopharmacological overview of Tribulus terrestris. Pharmacogn. Rev. 2014;8:45–51. doi: 10.4103/0973-7847.125530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sellami M., Slimeni O., Pokrywka A., Kuvačić G., Hayes L.D., Milic M., Padulo J. Herbal medicine for sports: A review. J. Int. Soc. Sports Nutr. 2018;15:14. doi: 10.1186/s12970-018-0218-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Qureshi A., Naughton D.P., Petroczi A. A systematic review on the herbal extract Tribulus terrestris and the roots of its putative aphrodisiac and performance enhancing effect. J. Diet. Suppl. 2014;11:64–79. doi: 10.3109/19390211.2014.887602. [DOI] [PubMed] [Google Scholar]
  • 11.Pokrywka A., Obmiński Z., Malczewska-Lenczowska J., Fijałek Z., Turek-Lepa E., Grucza R. Insights into supplements with Tribulus terrestris used by athletes. J. Hum. Kinet. 2014;41:99–105. doi: 10.2478/hukin-2014-0037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ma Y., Guo Z., Wang X. Tribulus terrestris extracts alleviate muscle damage and promote anaerobic performance of trained male boxers and its mechanisms: Roles of androgen, IGF-1, and IGF binding protein-3. J. Sport Health Sci. 2017;6:474–481. doi: 10.1016/j.jshs.2015.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Yin L., Wang Q., Wang X., Song L.-N. Effects of Tribulus terrestris saponins on exercise performance in overtraining rats and the underlying mechanisms. Can. J. Physiol. Pharmacol. 2016;94:1193–1201. doi: 10.1139/cjpp-2016-0086. [DOI] [PubMed] [Google Scholar]
  • 14.Rogerson S., Riches C.J., Jennings C., Weatherby R.P., Meir R.A., Marshall-Gradisnik S.M. The effect of five weeks of Tribulus terrestris supplementation on muscle strength and body composition during preseason training in elite rugby league players. J. Strength Cond. Res. 2007;21:348–353. doi: 10.1519/R-18395.1. [DOI] [PubMed] [Google Scholar]
  • 15.Fernández-Lázaro D., Mielgo-Ayuso J., Soto M.D.V., Adams D.P., González-Bernal J.J., Seco-Calvo J. The Effects of 6 Weeks of Tribulus terrestris L. Supplementation on Body Composition, Hormonal Response, Perceived Exertion, and CrossFit® Performance: A Randomized, Single-Blind, Placebo-Controlled Study. Nutrients. 2021;13:3696. doi: 10.3390/nu13113969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Heidari M.R., Mehrabani M., Pardakhty A., Khazaeli P., Zahedi M.J., Yakhchali M., Vahedian M. The analgesic effect of Tribulus terrestris extract and comparison of gastric ulcerogenicity of the extract with indomethacine in animal experiments. Ann. N. Y. Acad. Sci. 2007;1095:418–427. doi: 10.1196/annals.1397.045. [DOI] [PubMed] [Google Scholar]
  • 17.Talemi M.N.P.E., Ardakani S.M.P., Roozbeh B. Tribulus terrestris may decrease muscle damage markers following a high-intensity resistance exercise: A pilot study. Int. J. Vitam. Nutr. Res. 2021;91:500–506. doi: 10.1024/0300-9831/a000649. [DOI] [PubMed] [Google Scholar]
  • 18.Alzahrani S., Ezzat W., Elshaer R.E., Abd El-Lateef A.S., Mohammad H.M.F., Elkazaz A.Y., Toraih E., Zaitone S.A. Standardized Tribulus terrestris extract protects against rotenone-induced oxidative damage and nigral dopamine neuronal loss in mice. J. Physiol. Pharmacol. 2018;69:979–994. doi: 10.26402/jpp.2018.6.14. [DOI] [PubMed] [Google Scholar]
  • 19.Fernández-Lázaro D., Mielgo-Ayuso J., del Valle Soto M., Adams D.P., Gutiérrez-Abejón E., Seco-Calvo J. Impact of Optimal Timing of Intake of Multi-Ingredient Performance Supplements on Sports Performance, Muscular Damage, and Hormonal Behavior across a Ten-Week Training Camp in Elite Cyclists: A Randomized Clinical Trial. Nutrients. 2021;13:3746. doi: 10.3390/nu13113746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Page M.J., Moher D., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi: 10.1136/bmj.n160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Law M., Stewart C., Pollock N., Letts L., Bosch J., Westmorland M. Guidelines for Critical Review of Qualitative Studies. McMaster University Occupational Therapy Evidence-Based Practice Research Group; Hamilton, ON, Canada: 1998. pp. 1–9. [Google Scholar]
  • 22.Milasius K., Dadeliene R., Skernevicius J. The influence of the Tribulus terrestris extract on the parameters of the functional preparedness and athletes’ organism homeostasis. Fiziol. Zh. 2009;55:89–96. [PubMed] [Google Scholar]
  • 23.Poprzecki S., Zebrowska A., Cholewa J. Ergogenic effects of Tribulus terrestris supplementation in men by. J. Hum. Kinet. 2005;13:41–50. [Google Scholar]
  • 24.Wilk M., Michalczyk M., Chycki J., Maszczyk A., Czuba M., Roczniok R., Wilk M., Zając A. Endocrine Responses to Physical Training and Tribulus terrestris Supplementation in Middle-Age Men. Cent. Eur. J. Sport Sci. Med. 2016;13:65–71. [Google Scholar]
  • 25.Akhtari E., Raisi F., Keshavarz M., Hosseini H., Sohrabvand F., Bioos S., Kamalinejad M., Ghobadi A. Tribulus terrestris for treatment of sexual dysfunction in women: Randomized double-blind placebo-controlled study. Daru. 2014;22:40. doi: 10.1186/2008-2231-22-40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kamenov Z., Fileva S., Kalinov K., Jannini E.A. Evaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction—A prospective, randomized, double-blind, placebo-controlled clinical trial. Maturitas. 2017;99:20–26. doi: 10.1016/j.maturitas.2017.01.011. [DOI] [PubMed] [Google Scholar]
  • 27.Jameel J.K.A., Kneeshaw P.J., Rao V.S.R., Drew P.J. Gynaecomastia and the plant product “Tribulis terrestris”. Breast. 2004;13:428–430. doi: 10.1016/j.breast.2003.10.013. [DOI] [PubMed] [Google Scholar]
  • 28.Campanelli M., De Thomasis R., Tenaglia R.L. Priapism caused by ‘Tribulus terrestris’. Int. J. Impot. Res. 2016;28:39–40. doi: 10.1038/ijir.2015.30. [DOI] [PubMed] [Google Scholar]
  • 29.Ryan M., Lazar I., Nadasdy G.M., Nadasdy T., Satoskar A.A. Acute kidney injury and hyperbilirubinemia in a young male after ingestion of Tribulus terrestris. Clin. Nephrol. 2015;83:177–183. doi: 10.5414/CN108324. [DOI] [PubMed] [Google Scholar]
  • 30.Talasaz A.H., Abbasi M.R., Abkhiz S., Dashti-Khavidaki S. Tribulus terrestris-induced severe nephrotoxicity in a young healthy male. Nephrol. Dial. Transplant. 2010;25:3792–3793. doi: 10.1093/ndt/gfq457. [DOI] [PubMed] [Google Scholar]
  • 31.Alonso Lebrero E., Manuel Barat Baviera J., Pilar Conchello Moreno M., Estruch Riba R., Antonia Ferrús Pérez M., Font Pérez G. Report of the Scientific Committee of the Spanish Agency for Consumer Affairs, Food Safety and Nutrition (AECOSAN) on the conditions of use of certain substances to be used in food supplements. J. Sci. Comm. AESAN. 2015;22:79–131. [Google Scholar]
  • 32.Gandhi S., Srinivasan B.P., Akarte A.S. Potential nephrotoxic effects produced by steroidal saponins from hydro alcoholic extract of Tribulus terrestris in STZ-induced diabetic rats. Toxicol. Mech. Methods. 2013;23:548–557. doi: 10.3109/15376516.2013.797533. [DOI] [PubMed] [Google Scholar]
  • 33.World Anti-Doping Agency (WADA) The Prohibited List. [(accessed on 17 May 2021)]. Available online: https://www.wada-ama.org/en/prohibited-list.
  • 34.Coviello A.D., Kaplan B., Lakshman K.M., Chen T., Singh A.B., Bhasin S. Effects of Graded Doses of Testosterone on Erythropoiesis in Healthy Young and Older Men. J. Clin. Endocrinol. Metab. 2008;93:914–919. doi: 10.1210/jc.2007-1692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Tilwari A., Devi P.U., Prabha B., Shukla N.P. Immunomodulatory effect of fractions of saponins from Tribulus terrestris on non-specific immunity using in vitro phagocytosis. Int. J. Drug Discov. Herb. Res. 2011;1:202–207. [Google Scholar]
  • 36.Tilwari A., Shukla N., Devi P.U. Effect of five medicinal plants used in Indian system of medicines on immune function in Wistar rats. Afr. J. Biotechnol. 2013;10:16637–16645. [Google Scholar]
  • 37.Fernández-Lázaro D., Fernandez-Lazaro C.I., Mielgo-Ayuso J., Adams D.P., García Hernández J.L., González-Bernal J., González-Gross M. Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2. Front. Immunol. 2021;12:698672. doi: 10.3389/fimmu.2021.698672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Fernández-Lázaro D., González-Bernal J.J., Sánchez-Serrano N., Navascués L.J., Del Río A.A., Mielgo-Ayuso J. Physical exercise as a multimodal tool for COVID-19: Could it be used as a preventive strategy? Int. J. Environ. Res. Public Health. 2020;17:8496. doi: 10.3390/ijerph17228496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Zhang S., Li H., Yang S.J. Tribulosin protects rat hearts from ischemia/reperfusion injury. Acta Pharmacol. Sin. 2010;31:671–678. doi: 10.1038/aps.2010.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Rajendar B., Bharavi K., Rao G.S., Kishore P.V.S., Ravi Kumar P., Satish Kumar C.S.V., Patel T.P. Protective effect of an aphrodisiac herb Tribulus terrestris Linn on cadmium-induced testicular damage. Indian J. Pharmacol. 2011;43:568–573. doi: 10.4103/0253-7613.84974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Li M., Qu W., Wang Y., Wan H., Tian C. Hypoglycemic effect of saponin from Tribulus terrestris. Zhong Yao Cai = Zhongyaocai = J. Chin. Med. Mater. 2002;25:420–422. [PubMed] [Google Scholar]
  • 42.Oh J.S., Baik S.H., Ahn E.-K., Jeong W., Hong S.S. Anti-inflammatory activity of Tribulus terrestris in RAW264.7 Cells (54.2) J. Immunol. 2012;188:54–62. [Google Scholar]
  • 43.Lombardo B., Izzo V., Terracciano D., Ranieri A., Mazzaccara C., Fimiani F., Cesaro A., Gentile L., Leggiero E., Pero R., et al. Laboratory medicine: Health evaluation in elite athletes. Clin. Chem. Lab. Med. 2019;57:1450–1473. doi: 10.1515/cclm-2018-1107. [DOI] [PubMed] [Google Scholar]
  • 44.Almasi F., Khazaei M., Chehrei S., Ghanbari A. Hepatoprotective Effects of Tribulus terrestris Hydro-Alcholic Extract on Non-Alcoholic Fatty Liver-Induced Rats. Int. J. Morphol. 2017;35:345–350. doi: 10.4067/S0717-95022017000100054. [DOI] [Google Scholar]
  • 45.Kavitha P., Ramesh R., Bupesh G., Stalin A., Subramanian P. Hepatoprotective activity of Tribulus terrestris extract against acetaminophen-induced toxicity in a freshwater fish (Oreochromis mossambicus) Vitr. Cell. Dev. Biol. Anim. 2011;47:698–706. doi: 10.1007/s11626-011-9457-9. [DOI] [PubMed] [Google Scholar]
  • 46.Ștefănescu R., Tero-Vescan A., Negroiu A., Aurică E., Vari C.E. A Comprehensive Review of the Phytochemical, Pharmacological, and Toxicological Properties of Tribulus terrestris L. Biomolecules. 2020;10:752. doi: 10.3390/biom10050752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Coutinho A.E., Chapman K.E. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol. Cell. Endocrinol. 2011;335:2–13. doi: 10.1016/j.mce.2010.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ranjithkumar R., Alhadidi Q., Shah Z.A., Ramanathan M. Tribulusterine Containing Tribulus terrestris Extract Exhibited Neuroprotection Through Attenuating Stress Kinases Mediated Inflammatory Mechanism: In Vitro and In Vivo Studies. Neurochem. Res. 2019;44:1228–1242. doi: 10.1007/s11064-019-02768-7. [DOI] [PubMed] [Google Scholar]
  • 49.Gunarathne R., Nadeeshani H., Lu A., Li J., Zhang B., Ying T., Lu J. Potential Nutraceutical Use of Tribulus terrestris L. in Human Health. Food Rev. Int. 2022;1:1–30. doi: 10.1080/87559129.2022.2067172. [DOI] [Google Scholar]
  • 50.Anand R., Patnaik G.K., Kulshreshtha D.K., Dhawan B.N. Activity of certain fractions of Tribulus terrestris fruits against experimentally induced urolithiasis in rats. Indian J. Exp. Biol. 1994;32:548–552. [PubMed] [Google Scholar]
  • 51.Aggarwal A., Tandon S., Kumar Singla S., Tandon C. A novel antilithiatic protein from Tribulus terrestris having cytoprotective potency. Protein Pept. Lett. 2012;19:812–819. doi: 10.2174/092986612801619552. [DOI] [PubMed] [Google Scholar]
  • 52.Rubio Pérez F.J., Franco Bonafonte L., Ibarretxe Guerediaga D., Oyon Belaza M.P., Ugarte Peyron P. Effect of an individualized physical exercise program on lipid profile in sedentary patients with cardiovascular risk factors. Clin. Investig. Arterioscler. 2017;29:201–208. doi: 10.1016/j.arteri.2017.02.002. [DOI] [PubMed] [Google Scholar]
  • 53.Kraus W.E., Houmard J.A., Duscha B.D., Knetzger K.J., Wharton M.B., McCartney J.S., Bales C.W., Henes S., Samsa G.P., Otvos J.D., et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N. Engl. J. Med. 2002;347:1483–1492. doi: 10.1056/NEJMoa020194. [DOI] [PubMed] [Google Scholar]
  • 54.Leon A.S., Sanchez O.A. Response of blood lipids to exercise training alone or combined with dietary intervention. Med. Sci. Sports Exerc. 2001;33:S502–S515. doi: 10.1097/00005768-200106001-00021. [DOI] [PubMed] [Google Scholar]
  • 55.Ruiz J.R., Mesa J.L.M., Mingorance I., Rodríguez-Cuartero A., Castillo M.J. Sports with a high degree of physical stress negatively affect plasma lipid profile. Rev. Española Cardiol. 2004;1:57, 499–506. [PubMed] [Google Scholar]
  • 56.Santos-Silva A., Rebelo M.I., Castro E.M.B., Belo L., Guerra A., Rego C., Quintanilha A. Leukocyte activation, erythrocyte damage, lipid profile and oxidative stress imposed by high competition physical exercise in adolescents. Clin. Chim. Acta. 2001;306:119–126. doi: 10.1016/S0009-8981(01)00406-5. [DOI] [PubMed] [Google Scholar]
  • 57.Khan S., Kabir H., Jalees F., Asif M., Naquvi K.J. Antihyperlipidemic potential of fruits of Tribulus terrestris Linn. Int. J. Biomed. Res. 2011;2:98–101. doi: 10.7439/ijbr.v2i1.79. [DOI] [Google Scholar]
  • 58.El-Tantawy W.H., Hassanin L.A. Hypoglycemic and hypolipidemic effects of alcoholic extract of Tribulus alatus in streptozotocin-induced diabetic rats: A comparative study with T. terrestris (Caltrop) Indian J. Exp. Biol. 2007;45:785–790. [PubMed] [Google Scholar]
  • 59.Chu S., Qu W., Pang X., Sun B., Huang X. Effect of saponin from Tribulus terrestris on hyperlipidemia. Zhong Yao Cai. 2003;26:341–344. [PubMed] [Google Scholar]
  • 60.Wang X., Wang R., Yin L., Liu G. Effects of Tribulus terrestris on immune function in over-trained rats and its mechanism: The role of glucocorticoid and glucocorticoid receptor. Endocr. Abstr. 2013;1:32. [Google Scholar]
  • 61.Gauthaman K., Ganesan A.P. The hormonal effects of Tribulus terrestris and its role in the management of male erectile dysfunction—An evaluation using primates, rabbit and rat. Phytomedicine. 2008;15:44–54. doi: 10.1016/j.phymed.2007.11.011. [DOI] [PubMed] [Google Scholar]
  • 62.Singh S., Nair V., Gupta Y.K. Evaluation of the aphrodisiac activity of Tribulus terrestris Linn. in sexually sluggish male albino rats. J. Pharmacol. Pharmacother. 2012;3:43–47. doi: 10.4103/0976-500X.92512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Iacono F., Prezioso D., Illiano E., Romeo G., Ruffo A., Amato B. Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily. BMC Surg. 2012;12:S23. doi: 10.1186/1471-2482-12-S1-S23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Zhu W., Du Y., Meng H., Dong Y., Li L. A review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestris. Chem. Cent. J. 2017;11:60. doi: 10.1186/s13065-017-0289-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Neychev V.K., Mitev V.I. The aphrodisiac herb Tribulus terrestris does not influence the androgen production in young men. J. Ethnopharmacol. 2005;101:319–323. doi: 10.1016/j.jep.2005.05.017. [DOI] [PubMed] [Google Scholar]
  • 66.Frystyk J. Exercise and the growth hormone-insulin-like growth factor axis. Med. Sci. Sports Exerc. 2010;42:58–66. doi: 10.1249/MSS.0b013e3181b07d2d. [DOI] [PubMed] [Google Scholar]
  • 67.Rosenberg I.H. Sarcopenia: Origins and clinical relevance. Clin. Geriatr. Med. 2011;27:337–339. doi: 10.1016/j.cger.2011.03.003. [DOI] [PubMed] [Google Scholar]
  • 68.Giannoulis M.G., Martin F.C., Nair K.S., Umpleby A.M., Sonksen P. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr. Rev. 2012;33:314–377. doi: 10.1210/er.2012-1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Díaz Martínez A.E., Alcaide Martín M.J., González-Gross M. Basal Values of Biochemical and Hematological Parameters in Elite Athletes. Int. J. Environ. Res. Public Health. 2022;19:3059. doi: 10.3390/ijerph19053059. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All results are shown in the study.


Articles from International Journal of Environmental Research and Public Health are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES